CO2 Laser Phototherapy for Management of Mature Burn Scars
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Jun 21, 2017
Trial Information
Current as of June 07, 2025
Completed
Keywords
ClinConnect Summary
Laser phototherapy has gained growing acceptance and popularity for management of burn scars. The most commonly used laser is the Carbon Dioxide (CO2) Laser. At this institution, the investigator has used CO2 for management of Burn Scars since 2012. While the existing literature and the investigator's anecdotal experience thus far has been positive overall, there is no conclusive evidence to support that CO2 does indeed improve the quality of mature burn scars
The primary objective of this study is to evaluate mature burn scars before and after treatment with CO2 for patients age 3-21 whil...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 3 to 21
- • Patients with mature burn scars that are at least two years old from burn injury and that have not previously undergone CO2 laser therapy for scar revision.
- • Scars in all body areas with the exception of face, genitals or hands will be considered eligible for the study
- • Entry into this study is open to pediatric patients of both genders.
- • Entry into this study is open to pediatric patients of all ethnic backgrounds.
- • Entry into this study is open to females of childbearing potential with a negative urine or serum pregnancy test
- Exclusion Criteria:
- • Patients with scars less than 2 years old
- • Patients with contraindications to laser treatment (i.e.: active acne infections/ treatment with isotretinoin, active Zoster infection)
- • Patients receiving other forms of scar revision therapy such as other laser types, steroid injections, or surgical excisions.
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Pirko Maguina, MD
Principal Investigator
UC Davis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials